Personalized Chemosensitivity Assays for Mesothelioma: Are They Worth the Effort?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 29351918.
- Also identified by DOI 10.1158/1078-0432.CCR-17-3493.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cell lines formed from an individual's tumor can be used to predict response to specific therapies and determine genomic predictors. For mesothelioma, where chemotherapy remains the backbone of current therapeutic paradigms, such assays could be used to treat patients with the most effective agents specific to their "chemical profile." <i>Clin Cancer Res; 24(7); 1513-5. ©2018 AACR</i><i>See related article by Schunselaar et al., p. 1761</i>.
Medical subject headings
- Lung Neoplasms
- Mesothelioma